| 9th Sep 2024 7:01 am |
RNS |
Extension of Warrants in Incanthera to 31 Mar 2025 |
| 9th Sep 2024 7:00 am |
RNS |
Half-year Report |
| 6th Aug 2024 1:41 pm |
RNS |
Holding(s) in Company |
| 28th Jun 2024 12:17 pm |
RNS |
Result of AGM |
| 6th Jun 2024 4:20 pm |
RNS |
Holding(s) in Company |
| 5th Jun 2024 2:01 pm |
RNS |
Notice of AGM & Annual Report & Accounts |
| 5th Jun 2024 7:00 am |
RNS |
Final Results |
| 3rd Jun 2024 10:09 am |
RNS |
Realisation-c£1.5m on sale of shares in Incanthera |
| 3rd May 2024 7:00 am |
RNS |
Holding(s) in Company |
| 24th Apr 2024 7:12 am |
RNS |
IMMUPHARMA AT BIO-EQUITY 2024 12-14 May |
| 19th Apr 2024 7:00 am |
RNS |
Grant of Share Options |
| 2nd Apr 2024 7:03 am |
RNS |
New intellectual property strategy initiated |
| 25th Mar 2024 7:25 am |
RNS |
Incanthera provides Comm'l Update/Revenue F'casts |
| 19th Mar 2024 7:00 am |
RNS |
Grant of Share Options |
| 14th Mar 2024 7:00 am |
RNS |
IMMUPHARMA AT BIO-EUROPE SPRING 2024 |
| 6th Mar 2024 7:00 am |
RNS |
Financial, Business and Portfolio Develop't Update |
| 28th Dec 2023 1:35 pm |
RNS |
Holding(s) in Company |
| 19th Dec 2023 2:50 pm |
RNS |
Holding(s) in Company |
| 19th Dec 2023 7:00 am |
RNS |
Simbec-Orion appointed as CRO |
| 18th Dec 2023 7:15 am |
RNS |
Incanthera - Comm'l Skincare Deal/£1M Fundraise |
| 13th Sep 2023 3:47 pm |
RNS |
Holding(s) in Company |
| 7th Sep 2023 7:00 am |
RNS |
Result of Retail Offer and Director Shareholding |
| 31st Aug 2023 7:02 am |
RNS |
WRAP Retail Offer for up to £0.5m |
| 31st Aug 2023 7:01 am |
RNS |
Subscription to raise £1.35m; Sharing Agr, RPT |
| 31st Aug 2023 7:00 am |
RNS |
Interim results |
| 21st Aug 2023 7:00 am |
RNS |
Extension of warrants in Incanthera plc |
| 11th Aug 2023 12:04 pm |
RNS |
Directorate Change |
| 30th Jun 2023 1:12 pm |
RNS |
Result of AGM |
| 19th Jun 2023 7:00 am |
RNS |
Lupuzor Update |
| 6th Jun 2023 7:00 am |
RNS |
IMM RNS Posting of RA and Notice of AGM 30 June 23 |
| 18th May 2023 7:00 am |
RNS |
Positive Pre-IND meeting with FDA |
| 11th May 2023 7:00 am |
RNS |
Final Results |
| 10th May 2023 1:56 pm |
RNS |
Holding(s) in Company |
| 19th Apr 2023 7:00 am |
RNS |
Lupozor Update - FDA confirms Type-C meeting date |
| 12th Apr 2023 7:00 am |
RNS |
CIDP P140 Clinical Program Update |
| 27th Mar 2023 7:00 am |
RNS |
Lupuzor™ Update |
| 9th Mar 2023 4:35 pm |
RNS |
Price Monitoring Extension |
| 6th Mar 2023 7:00 am |
RNS |
Collaboration with Orano on ImmuPharma Peptide |
| 6th Feb 2023 7:00 am |
RNS |
Lupuzor™ Update |
| 27th Jan 2023 4:25 pm |
RNS |
TR-1: Notification of major holdings |
